Stay updated on NasoVAX in Early COVID-19 Clinical Trial

Sign up to get notified when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NasoVAX in Early COVID-19 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The update consists of a site revision note (Revision: v3.3.2) replacing the previous v3.3.1; no changes to core study content or navigation evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:43.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Page shows Revision: v3.3.1 replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:41:27.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice that previously cautioned users about potential delays in updates; the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:48.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows Terminated Enrollment for NCT04442230, with the study status updated and enrollment closed.
    Difference
    0.5%
    Check dated 2025-11-03T01:20:43.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and version bump to v3.2.0; removed the previous v3.1.0 version reference.
    Difference
    4%
    Check dated 2025-10-05T10:07:41.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.5%
    Check dated 2025-09-28T03:14:40.000Z thumbnail image

Stay in the know with updates to NasoVAX in Early COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.